# Bortezomib

NDC: 83634-208
Generic name: bortezomib
Labeler / Manufacturer: Avenacy, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20260501

FDA application: ANDA216528

## Active ingredients

- BORTEZOMIB: 3.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"83634-208"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=83634-208
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=decb5d94-2ea2-48d8-b08b-3196b24c0ed3